Therapeutic targets for liver regeneration after acute severe injury: a preclinical overview

References

• Fausto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatology. 2006;43:S45–53.
   PubMed Web of Science ®Google Scholar
• Michalopoulos GK. Liver regeneration. J Cell Physiol. 2007;213:286–300.
   PubMed Web of Science ®Google Scholar
• Michalopoulos GK. Principles of liver regeneration and growth homeostasis. Compr Physiol. 2013;3:485–513.
   PubMed Web of Science ®Google Scholar
• Imamura H, Shimada R, Kubota M, et al. Preoperative portal vein embolization: an audit of 84 patients. Hepatology. 1999;29:1099–1105.
   PubMed Web of Science ®Google Scholar
• Adam R, Laurent A, Azoulay D, et al. Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors. Ann Surg. 2000;232:777–785.
   PubMed Web of Science ®Google Scholar
• Schnitzbauer AA, Lang SA, Goessmann H, et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg. 2012;255:405–414.
   PubMed Web of Science ®Google Scholar
• Henley KS, Lucey MR, Normolle DP, et al. A double-blind, randomized, placebo-controlled trial of prostaglandin E1 in liver transplantation. Hepatology. 1995;21:366–372.
   PubMed Web of Science ®Google Scholar
• Klein AS, Cofer JB, Pruett TL, et al. Prostaglandin E1 administration following orthotopic liver transplantation: a randomized prospective multicenter trial. Gastroenterology. 1996;111:710–715.
   PubMed Web of Science ®Google Scholar
• Nelson AR, Fingleton B, Rothenberg ML, et al. Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol. 2000;18:1135–1149.
   PubMed Web of Science ®Google Scholar
• Beck-Schimmer B, Bonvini JM, Schadde E, et al. Conditioning with sevoflurane in liver transplantation: results of a multicenter randomized controlled trial. Transplantation. 2015;99:1606–1612.
   PubMed Web of Science ®Google Scholar
• Selzner N, Rudiger H, Graf R, et al. Protective strategies against ischemic injury of the liver. Gastroenterology. 2003;125:917–936.
   PubMed Web of Science ®Google Scholar
• Nickkholgh A, Maluf D. Emerging graft protective strategies in clinical liver transplantation. Expert Rev Gastroenterol Hepatol. 2017;11:623–631.
   PubMed Web of Science ®Google Scholar
• Nasralla D, Coussios CC, Mergental H, et al. A randomized trial of normothermic preservation in liver transplantation. Nature. 2018;557:50–56.
   PubMed Web of Science ®Google Scholar
• Kelly DM, Demetris AJ, Fung JJ, et al. Porcine partial liver transplantation: a novel model of the “small-for-size” liver graft. Liver Transpl. 2004;10:253–263.
   PubMed Web of Science ®Google Scholar
• Eguchi S, Yanaga K, Sugiyama N, et al. Relationship between portal venous flow and liver regeneration in patients after living donor right-lobe liver transplantation. Liver Transpl. 2003;9:547–551.
   PubMed Web of Science ®Google Scholar
• Hessheimer AJ, Fondevila C, Taura P, et al. Decompression of the portal bed and twice-baseline portal inflow are necessary for the functional recovery of a “small-for-size” graft. Ann Surg. 2011;253:1201–1210.
   PubMed Web of Science ®Google Scholar
• Lorenz L, Axnick J, Buschmann T, et al. Mechanosensing by beta1 integrin induces angiocrine signals for liver growth and survival. Nature. 2018;562:128–132.
   PubMed Web of Science ®Google Scholar
• Zhai Y, Petrowsky H, Hong JC, et al. Ischaemia-reperfusion injury in liver transplantation–from bench to bedside. Nat Rev Gastroenterol Hepatol. 2013;10:79–89.
   PubMed Web of Science ®Google Scholar
• Fausto N. Liver regeneration: from laboratory to clinic. Liver Transpl. 2001;7:835–844.
   PubMed Web of Science ®Google Scholar
• Yagi S, Iida T, Taniguchi K, et al. Impact of portal venous pressure on regeneration and graft damage after living-donor liver transplantation. Liver Transpl. 2005;11:68–75.
   PubMed Web of Science ®Google Scholar
• Clavien PA, Petrowsky H, DeOliveira ML, et al. Strategies for safer liver surgery and partial liver transplantation. N Engl J Med. 2007;356:1545–1559.
   PubMed Web of Science ®Google Scholar
• Lee WM, Squires RH Jr., Nyberg SL, et al. Acute liver failure: summary of a workshop. Hepatology. 2008;47:1401–1415.
   PubMed Web of Science ®Google Scholar
• Clavien PA, Oberkofler CE, Raptis DA, et al. What is critical for liver surgery and partial liver transplantation: size or quality? Hepatology. 2010;52:715–729.
   PubMed Web of Science ®Google Scholar
• Breitenstein S, Apestegui C, Petrowsky H, et al. “State of the art” in liver resection and living donor liver transplantation: a worldwide survey of 100 liver centers. World J Surg. 2009;33:797–803.
   PubMed Web of Science ®Google Scholar
• Forbes SJ, Newsome PN. Liver regeneration - mechanisms and models to clinical application. Nat Rev Gastroenterol Hepatol. 2016;13:473–485.
   PubMed Web of Science ®Google Scholar
• de Santibanes E, Clavien PA. Playing Play-Doh to prevent postoperative liver failure: the “ALPPS” approach. Ann Surg. 2012;255:415–417.
   PubMed Web of Science ®Google Scholar
• Zhao B, Tumaneng K, Guan KL. The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat Cell Biol. 2011;13:877–883.
   PubMed Web of Science ®Google Scholar
• Liu Y, Lu T, Zhang C, et al. Activation of YAP attenuates hepatic damage and fibrosis in liver ischemia-reperfusion injury. J Hepatol. 2019;71:719–730.
   PubMed Web of Science ®Google Scholar
• Yimlamai D, Christodoulou C, Galli GG, et al. Hippo pathway activity influences liver cell fate. Cell. 2014;157:1324–1338.
   PubMed Web of Science ®Google Scholar
• Thompson MD, Monga SP. WNT/beta-catenin signaling in liver health and disease. Hepatology. 2007;45:1298–1305.
   PubMed Web of Science ®Google Scholar
• Tan X, Apte U, Micsenyi A, et al. Epidermal growth factor receptor: a novel target of the Wnt/beta-catenin pathway in liver. Gastroenterology. 2005;129:285–302.
   PubMed Web of Science ®Google Scholar
• Petrowsky H, Breitenstein S, Slankamenac K, et al. Effects of pentoxifylline on liver regeneration: a double-blinded, randomized, controlled trial in 101 patients undergoing major liver resection. Ann Surg. 2010;252:813–822.
   PubMed Web of Science ®Google Scholar
• Zhu XH, Wu YF, Qiu YD, et al. Liver-protecting effects of omega-3 fish oil lipid emulsion in liver transplantation. World J Gastroenterol. 2012;18:6141–6147.
   PubMed Web of Science ®Google Scholar
• Ibrahim ES, Saleh SM, El Hoseeny M, et al. Effect of omega-3 on hepatic regeneration in adult living donors undergoing hepatic resections for liver transplantation: A randomized controlled trial. J Crit Care. 2016;31:157–162.
   PubMed Web of Science ®Google Scholar
• Yan XP, Wang S, Yang Y, et al. Effects of n-3 polyunsaturated fatty acids on rat livers after partial hepatectomy via LKB1-AMPK signaling pathway. Transplant Proc. 2011;43:3604–3612.
   PubMed Web of Science ®Google Scholar
• Zhong D, Liu X, Khuri FR, et al. LKB1 is necessary for Akt-mediated phosphorylation of proapoptotic proteins. Cancer Res. 2008;68:7270–7277.
   PubMed Web of Science ®Google Scholar
• Martinez-Chantar ML, Vazquez-Chantada M, Garnacho M, et al. S-adenosylmethionine regulates cytoplasmic HuR via AMP-activated kinase. Gastroenterology. 2006;131:223–232.
   PubMed Web of Science ®Google Scholar
• Merlen G, Gentric G, Celton-Morizur S, et al. AMPKalpha1 controls hepatocyte proliferation independently of energy balance by regulating Cyclin A2 expression. J Hepatol. 2014;60:152–159.
   PubMed Web of Science ®Google Scholar
• Padickakudy R, Pereyra D, Offensperger F, et al. Bivalent role of intra-platelet serotonin in liver regeneration and tumor recurrence in humans. J Hepatol. 2017;67:1243–1252.
   PubMed Web of Science ®Google Scholar
• Myronovych A, Murata S, Chiba M, et al. Role of platelets on liver regeneration after 90% hepatectomy in mice. J Hepatol. 2008;49:363–372.
   PubMed Web of Science ®Google Scholar
• Lesurtel M, Graf R, Aleil B, et al. Platelet-derived serotonin mediates liver regeneration. Science. 2006;312:104–107.
   PubMed Web of Science ®Google Scholar
• Starlinger P, Haegele S, Offensperger F, et al. The profile of platelet alpha-granule released molecules affects postoperative liver regeneration. Hepatology. 2016;63:1675–1688.
   PubMed Web of Science ®Google Scholar
• Sarrouilhe D, Clarhaut J, Defamie N, et al. Serotonin and cancer: what is the link? Curr Mol Med. 2015;15:62–77.
   PubMed Web of Science ®Google Scholar
• Garg V, Garg H, Khan A, et al. Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure. Gastroenterology. 2012;142:505–512 e501.
   PubMed Web of Science ®Google Scholar
• Alvarenga DM, Mattos MS, Lopes ME, et al. Paradoxical role of matrix metalloproteinases in liver injury and regeneration after sterile acute hepatic failure. Cells. 2018;7:247.
   Web of Science ®Google Scholar
• Peiseler M, Kubes P. More friend than foe: the emerging role of neutrophils in tissue repair. J Clin Invest. 2019;129:2629–2639.
   PubMed Web of Science ®Google Scholar
• Otao R, Beppu T, Isiko T, et al. External biliary drainage and liver regeneration after major hepatectomy. Br J Surg. 2012;99:1569–1574.
   PubMed Web of Science ®Google Scholar
• Alvarez-Sola G, Uriarte I, Latasa MU, et al. Bile acids, FGF15/19 and liver regeneration: from mechanisms to clinical applications. Biochim Biophys Acta Mol Basis Dis. 2018;1864:1326–1334.
   PubMed Web of Science ®Google Scholar
• Naugler WE, Tarlow BD, Fedorov LM, et al. Fibroblast growth factor signaling controls liver size in mice with humanized livers. Gastroenterology. 2015;149:728–740 e715.
   PubMed Web of Science ®Google Scholar
• Chen WD, Wang YD, Zhang L, et al. Farnesoid X receptor alleviates age-related proliferation defects in regenerating mouse livers by activating forkhead box m1b transcription. Hepatology. 2010;51:953–962.
   PubMed Web of Science ®Google Scholar
• Padrissa-Altes S, Bachofner M, Bogorad RL, et al. Control of hepatocyte proliferation and survival by Fgf receptors is essential for liver regeneration in mice. Gut. 2015;64:1444–1453.
   PubMed Web of Science ®Google Scholar
• Olthof PB, Huisman F, Schaap FG, et al. Effect of obeticholic acid on liver regeneration following portal vein embolization in an experimental model. Br J Surg. 2017;104:590–599.
   PubMed Web of Science ®Google Scholar
• Alvarez-Sola G, Uriarte I, Latasa MU, et al. Fibroblast growth factor 15/19 (FGF15/19) protects from diet-induced hepatic steatosis: development of an FGF19-based chimeric molecule to promote fatty liver regeneration. Gut. 2017;66:1818–1828.
   PubMed Web of Science ®Google Scholar
• Neuschwander-Tetri BA, Loomba R, Sanyal AJ, et al. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial. Lancet. 2015;385:956–965.
   PubMed Web of Science ®Google Scholar
• Hirschfield GM, Chazouilleres O, Drenth JP, et al. Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial. J Hepatol. 2019;70:483–493.
   PubMed Web of Science ®Google Scholar
• Basta G, Del Turco S, Navarra T, et al. Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure. Liver Transpl. 2015;21:847–854.
   PubMed Web of Science ®Google Scholar
• Zeng S, Feirt N, Goldstein M, et al. Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice. Hepatology. 2004;39:422–432.
   PubMed Web of Science ®Google Scholar
• Cataldegirmen G, Zeng S, Feirt N, et al. RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-alpha and NF-kappaB. J Exp Med. 2005;201:473–484.
   PubMed Web of Science ®Google Scholar
• Koh EJ, Yoon SJ, Lee SM. Losartan protects liver against ischaemia/reperfusion injury through PPAR-gamma activation and receptor for advanced glycation end-products down-regulation. Br J Pharmacol. 2013;169:1404–1416.
   PubMed Web of Science ®Google Scholar
• Aravinthan AD, Alexander GJM. Senescence in chronic liver disease: is the future in aging? J Hepatol. 2016;65:825–834.
   PubMed Web of Science ®Google Scholar
• Bird TG, Muller M, Boulter L, et al. TGFbeta inhibition restores a regenerative response in acute liver injury by suppressing paracrine senescence. Sci Transl Med. 2018;10.
   PubMed Web of Science ®Google Scholar
• Faivre S, Santoro A, Kelley RK, et al. Novel transforming growth factor beta receptor I kinase inhibitor galunisertib (LY2157299) in advanced hepatocellular carcinoma. Liver Int. 2019;39:1468–1477.
   PubMed Web of Science ®Google Scholar
• Toshima T, Shirabe K, Fukuhara T, et al. Suppression of autophagy during liver regeneration impairs energy charge and hepatocyte senescence in mice. Hepatology. 2014;60:290–300.
   PubMed Web of Science ®Google Scholar
• Truant S, Bouras AF, Petrovai G, et al. Volumetric gain of the liver after major hepatectomy in obese patients: a case-matched study in 84 patients. Ann Surg. 2013;258:696–702, discussion 702-694
   PubMed Web of Science ®Google Scholar
• Kele PG, van der Jagt EJ, Gouw AS, et al. The impact of hepatic steatosis on liver regeneration after partial hepatectomy. Liver Int. 2013;33:469–475.
   PubMed Web of Science ®Google Scholar
• Vetelainen R, van Vliet AK, van Gulik TM. Severe steatosis increases hepatocellular injury and impairs liver regeneration in a rat model of partial hepatectomy. Ann Surg. 2007;245:44–50.
   PubMed Web of Science ®Google Scholar
• Selzner M, Rudiger HA, Sindram D, et al. Mechanisms of ischemic injury are different in the steatotic and normal rat liver. Hepatology. 2000;32:1280–1288.
   PubMed Web of Science ®Google Scholar
• Selzner M, Clavien PA. Failure of regeneration of the steatotic rat liver: disruption at two different levels in the regeneration pathway. Hepatology. 2000;31:35–42.
   PubMed Web of Science ®Google Scholar
• Ogrodnik M, Miwa S, Tchkonia T, et al. Cellular senescence drives age-dependent hepatic steatosis. Nat Commun. 2017;8:15691.
   PubMed Web of Science ®Google Scholar
• Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22:696–699.
   PubMed Web of Science ®Google Scholar
• Melin C, Miick R, Young NA, et al. Approach to intraoperative consultation for donor liver biopsies. Arch Pathol Lab Med. 2013;137:270–274.
   PubMed Web of Science ®Google Scholar
• Wadhera V, Harimoto N, Lubezky N, et al. The impact of donor liver allograft fibrosis on patients undergoing liver transplantation. Clin Transplant. 2018;32:e13187.
   PubMed Web of Science ®Google Scholar
• Ikegami T, Nishizaki T, Yanaga K, et al. The impact of donor age on living donor liver transplantation. Transplantation. 2000;70:1703–1707.
   PubMed Web of Science ®Google Scholar
• Ono Y, Kawachi S, Hayashida T, et al. The influence of donor age on liver regeneration and hepatic progenitor cell populations. Surgery. 2011;150:154–161.
   PubMed Web of Science ®Google Scholar
• Kubota T, Hata K, Sozu T, et al. Impact of donor age on recipient survival in adult-to-adult living-donor liver transplantation. Ann Surg. 2018;267:1126–1133.
   PubMed Web of Science ®Google Scholar
• Ito Y, Sorensen KK, Bethea NW, et al. Age-related changes in the hepatic microcirculation in mice. Exp Gerontol. 2007;42:789–797.
   PubMed Web of Science ®Google Scholar
• Selzner M, Selzner N, Jochum W, et al. Increased ischemic injury in old mouse liver: an ATP-dependent mechanism. Liver Transpl. 2007;13:382–390.
   PubMed Web of Science ®Google Scholar
• Wiley CD, Velarde MC, Lecot P, et al. Mitochondrial dysfunction induces senescence with a distinct secretory phenotype. Cell Metab. 2016;23:303–314.
   PubMed Web of Science ®Google Scholar
• Enkhbold C, Morine Y, Utsunomiya T, et al. Dysfunction of liver regeneration in aged liver after partial hepatectomy. J Gastroenterol Hepatol. 2015;30:1217–1224.
   PubMed Web of Science ®Google Scholar
• Simoneau E, Alanazi R, Alshenaifi J, et al. Neoadjuvant chemotherapy does not impair liver regeneration following hepatectomy or portal vein embolization for colorectal cancer liver metastases. J Surg Oncol. 2016;113:449–455.
   PubMed Web of Science ®Google Scholar
• Yokoyama Y, Ebata T, Igami T, et al. The adverse effects of preoperative cholangitis on the outcome of portal vein embolization and subsequent major hepatectomies. Surgery. 2014;156:1190–1196.
   PubMed Web of Science ®Google Scholar
• Takagi T, Yokoyama Y, Kokuryo T, et al. Liver regeneration following experimental major hepatectomy with choledochojejunostomy. Br J Surg. 2015;102:1410–1417.
   PubMed Web of Science ®Google Scholar
• Ferreira-Gonzalez S, Lu WY, Raven A, et al. Paracrine cellular senescence exacerbates biliary injury and impairs regeneration. Nat Commun. 2018;9:1020.
   PubMed Web of Science ®Google Scholar
• Stutchfield BM, Antoine DJ, Mackinnon AC, et al. CSF1 restores innate immunity after liver injury in mice and serum levels indicate outcomes of patients with acute liver failure. Gastroenterology. 2015;149:1896–1909 e1814.
   PubMed Web of Science ®Google Scholar
• Antoine DJ, Jenkins RE, Dear JW, et al. Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity. J Hepatol. 2012;56:1070–1079.
   PubMed Web of Science ®Google Scholar
• VandePol CJ, Garnick MB. Clinical applications of recombinant macrophage-colony stimulating factor (rhM-CSF). Biotechnol Ther. 1991;2:231–239.
   PubMedGoogle Scholar
• Catalanotto C, Cogoni C, Zardo G. MicroRNA in control of gene expression: an overview of nuclear functions. Int J Mol Sci. 2016;17:1712.
   Web of Science ®Google Scholar
• Ng R, Song G, Roll GR, et al. A microRNA-21 surge facilitates rapid cyclin D1 translation and cell cycle progression in mouse liver regeneration. J Clin Invest. 2012;122:1097–1108.
   PubMed Web of Science ®Google Scholar
• Yang D, Yuan Q, Balakrishnan A, et al. MicroRNA-125b-5p mimic inhibits acute liver failure. Nat Commun. 2016;7:11916.
   PubMed Web of Science ®Google Scholar
• Lv T, Kong L, Jiang L, et al. Dicer1 facilitates liver regeneration in a manner dependent on the inhibitory effect of miR-21 on Pten and Rhob expression. Life Sci. 2019;232:116656.
   PubMed Web of Science ®Google Scholar
• John K, Hadem J, Krech T, et al. MicroRNAs play a role in spontaneous recovery from acute liver failure. Hepatology. 2014;60:1346–1355.
   PubMed Web of Science ®Google Scholar
• Lu WY, Bird TG, Boulter L, et al. Hepatic progenitor cells of biliary origin with liver repopulation capacity. Nat Cell Biol. 2015;17:971–983.
   PubMed Web of Science ®Google Scholar
• Schiodt FV, Ostapowicz G, Murray N, et al. Alpha-fetoprotein and prognosis in acute liver failure. Liver Transpl. 2006;12:1776–1781.
   PubMed Web of Science ®Google Scholar
• Nyberg SL. Bridging the gap: advances in artificial liver support. Liver Transpl. 2012;18(Suppl 2):S10–14.
   PubMedGoogle Scholar
• Demetriou AA, Brown RS Jr., Busuttil RW, et al. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg. 2004;239:660–667, discussion 667-670
   PubMed Web of Science ®Google Scholar
• Thompson J, Jones N, Al-Khafaji A, et al. Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: A multinational, prospective, controlled, randomized trial. Liver Transpl. 2018;24:380–393.
   PubMed Web of Science ®Google Scholar
• Soltys KA, Setoyama K, Tafaleng EN, et al. Host conditioning and rejection monitoring in hepatocyte transplantation in humans. J Hepatol. 2017;66:987–1000.
   PubMed Web of Science ®Google Scholar
• Liu WH, Song FQ, Ren LN, et al. The multiple functional roles of mesenchymal stem cells in participating in treating liver diseases. J Cell Mol Med. 2015;19:511–520.
   PubMed Web of Science ®Google Scholar
• Katagiri H, Kushida Y, Nojima M, et al. A distinct subpopulation of bone marrow mesenchymal stem cells, muse cells, directly commit to the replacement of liver components. Am J Transplant. 2016;16:468–483.
   PubMed Web of Science ®Google Scholar
• Gazdic M, Arsenijevic A, Markovic BS, et al. Mesenchymal stem cell-dependent modulation of liver diseases. Int J Biol Sci. 2017;13:1109–1117.
   PubMed Web of Science ®Google Scholar
• Mohamadnejad M, Alimoghaddam K, Bagheri M, et al. Randomized placebo-controlled trial of mesenchymal stem cell transplantation in decompensated cirrhosis. Liver Int. 2013;33:1490–1496.
   PubMed Web of Science ®Google Scholar
• Kajiwara M, Aoi T, Okita K, et al. Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells. Proc Natl Acad Sci U S A. 2012;109:12538–12543.
   PubMed Web of Science ®Google Scholar
• Huang P, Zhang L, Gao Y, et al. Direct reprogramming of human fibroblasts to functional and expandable hepatocytes. Cell Stem Cell. 2014;14:370–384.
   PubMed Web of Science ®Google Scholar
• Greenbaum LE, Wells RG. The role of stem cells in liver repair and fibrosis. Int J Biochem Cell Biol. 2011;43:222–229.
   PubMed Web of Science ®Google Scholar
• Michalopoulos GK, Khan Z. Liver stem cells: experimental findings and implications for human liver disease. Gastroenterology. 2015;149:876–882.
   PubMed Web of Science ®Google Scholar
• Raven A, Lu WY, Man TY, et al. Cholangiocytes act as facultative liver stem cells during impaired hepatocyte regeneration. Nature. 2017;547:350–354.
   PubMed Web of Science ®Google Scholar
• Huch M, Gehart H, van Boxtel R, et al. Long-term culture of genome-stable bipotent stem cells from adult human liver. Cell. 2015;160:299–312.
   PubMed Web of Science ®Google Scholar
• Yovchev MI, Xue Y, Shafritz DA, et al. Repopulation of the fibrotic/cirrhotic rat liver by transplanted hepatic stem/progenitor cells and mature hepatocytes. Hepatology. 2014;59:284–295.
   PubMed Web of Science ®Google Scholar
• Uygun BE, Soto-Gutierrez A, Yagi H, et al. Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med. 2010;16:814–820.
   PubMed Web of Science ®Google Scholar
• Kojima H, Yasuchika K, Fukumitsu K, et al. Establishment of practical recellularized liver graft for blood perfusion using primary rat hepatocytes and liver sinusoidal endothelial cells. Am J Transplant. 2018;18:1351–1359.
   PubMed Web of Science ®Google Scholar
• Takebe T, Sekine K, Enomura M, et al. Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature. 2013;499:481–484.
   PubMed Web of Science ®Google Scholar
• Zhu J, Lu T, Yue S, et al. Rapamycin protection of livers from ischemia and reperfusion injury is dependent on both autophagy induction and mammalian target of rapamycin complex 2-Akt activation. Transplantation. 2015;99:48–55.
   PubMed Web of Science ®Google Scholar
• Sellaro TL, Ranade A, Faulk DM, et al. Maintenance of human hepatocyte function in vitro by liver-derived extracellular matrix gels. Tissue Eng Part A. 2010;16:1075–1082.
   PubMed Web of Science ®Google Scholar
• Hu H, Gehart H, Artegiani B, et al. Long-term expansion of functional mouse and human hepatocytes as 3D Organoids. Cell. 2018;175:1591–1606 e1519.
   PubMed Web of Science ®Google Scholar
• Peng WC, Logan CY, Fish M, et al. Inflammatory cytokine TNFalpha promotes the long-term expansion of primary hepatocytes in 3D culture. Cell. 2018;175:1607–1619 e1615.
   PubMed Web of Science ®Google Scholar
• Soto-Gutierrez A, Wertheim JA, Ott HC, et al. Perspectives on whole-organ assembly: moving toward transplantation on demand. J Clin Invest. 2012;122:3817–3823.
   PubMed Web of Science ®Google Scholar